COVID-19 Clinical Trial Site Expansion into India
(World News Brazil)

2 July 2020 ASX Code: MXC COVID-19 Clinical Trial Update - Site expansion into India, WHO selection for research task force Key Highlights: • The World Health Organisation (WHO) has established a COVID-19 taskforce and selected MGC Pharma to participate in obtaining mapping and assessment of all ongoing research • MXC has expanded patient recruitment of its ArtemiC Phase II clinical trial on patients diagnosed with COVID-19 to the Mahatma Gandhi Mission`s Medical College & Hospital in Aurangabad, India • Full Ethics Committee approval has been received at Mahatma Gandhi Mission`s Medical College & Hospital in India • According to WHO data, there have been 18,653 people in India...